The journey of a new drug from a scientific discovery to a usable medicine is long, complex, and fraught with challenges. It’s a high-stakes race where only a handful of candidates ever cross the finish line. At the very beginning of this journey, a critical phase known as preclinical development takes place. This is where a compound is tested extensively in laboratory settings and animal models to ensure it is safe and effective enough to be tested in humans. Navigating this phase requires immense resources, specialized expertise, and sophisticated infrastructure—elements that are often provided by a Preclinical Contract Research Organization (CRO).
Demystifying the Preclinical CRO
A Preclinical Contract Research Organization (CRO) is an external company that provides specialized research services to the pharmaceutical, biotechnology, and medical device industries. Instead of conducting all research in-house, these companies outsource specific tasks or entire projects to a CRO. The “preclinical” part of … Read more